News & Events about Aptargroup Inc.
Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery systems, services and active material science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump developed to deliver nasal saline and other comparable...
Shares of AptarGroup, Inc. (NYSE:ATR Get Rating) have earned an average rating of Moderate Buy from the eight brokerages that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. ...
Market News Video
3 months ago
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two ...
Globe Newswire
4 months ago
Visiongain has published a new report on Therapeutic Respiratory Devices Market, 2021-2031. Forecasts By Product {Nebulizers (Compressor-Based Nebulizers, Piston-Based Hand-Held Nebulizers, Ultrasonic Nebulizers), Humidifiers (Heated Humidifiers, Passover Humidifiers, Integrated Humidifiers, Built-...
Citigroup Inc. cut its stake in AptarGroup, Inc. (NYSE:ATR Get Rating) by 16.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,389 shares of the industrial products companys stock after selling 3,889 ...